Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
- Conditions
- Panic Disorder
- First Posted Date
- 2007-08-14
- Last Posted Date
- 2007-08-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00515996
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome
Completed
- Conditions
- Prader Willi SyndromeObesity
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2007-05-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 51
- Registration Number
- NCT00474643
The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1200
- Registration Number
- NCT00418860
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma, T-Cell
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2009-10-21
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00418535
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus
Completed
- Conditions
- Globus Pharyngeus
- Interventions
- Behavioral: Conservative management for xerostomia
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2010-07-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 340
- Registration Number
- NCT00381771
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
Phase 1
Completed
- Conditions
- Peripheral T-Cell LymphomasNon-Hodgkin Lymphoma
- First Posted Date
- 2006-09-11
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT00374699
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
Phase 1
Completed
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2006-09-04
- Last Posted Date
- 2006-09-04
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00371410
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Phase 4
Completed
- Conditions
- NeuroblastomaWilms TumorBrain TumorRetinoblastomaMycoses
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2008-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00336531
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase 2
Suspended
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndrome
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2006-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00329498
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2010-08-27
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00329472
© Copyright 2025. All Rights Reserved by MedPath